Kristina Sachs-Barrable

Potential Mechanisms by Which Peceol® Increases the Gastrointestinal Absorption of Amphotericin B

Michael Boyd, K. Wasan, Verica Risovic, 2004, Drug development and industrial pharmacy.

Enhancing drug absorption using lipids: a case study presenting the development and pharmacological evaluation of a novel lipid-based oral amphotericin B formulation for the treatment of systemic fungal infections.

E. Wasan, K. Wasan, Kristina Sachs-Barrable, 2008, Advanced drug delivery reviews.

Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.

K. Wasan, Kristina Sachs-Barrable, Kishor M Wasan, 2007, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

The use of the United States FDA programs as a strategy to advance the development of drug products for neglected tropical diseases

Fady Ibrahim, P. Gershkovich, K. Wasan, 2014, Drug development and industrial pharmacy.

Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery

Dion R. Brocks, D. Brocks, K. Wasan, 2008, Nature Reviews Drug Discovery.

Effects of monoglycerides on P-glycoprotein: modulation of the activity and expression in Caco-2 cell monolayers.

K. Wasan, Kristina Sachs-Barrable, Kishor M Wasan, 2008, Molecular pharmaceutics.